BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EDK060 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of EDK060\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07140614-11252@assetmemo.bio
DTSTAMP:20261121T005422Z
DTSTART;VALUE=DATE:20280225
DTEND;VALUE=DATE:20280226
SUMMARY:EDK060: Phase 1 readout est. (NCT07140614)
DESCRIPTION:EDK060\, phase 1\, Charcot-Marie-Tooth Disease.\nStudy: A First
  in Human Study to Assess the Safety\, Tolerability\, and Pharmacokinetics
  of EDK060 in Adults With CMT1A.\nEstimated primary completion: 25 Februar
 y 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/edk060#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07140614
URL:https://assetmemo.bio/drug/edk060#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
